ResearcherCharles UniversityActive in the last 2 years
Tomas Sychra
Matched on ORCID iD 0000-0002-6239-5779; OpenAlex author ID A5026168911, A5083731515. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 4
- Determinants of Implantation Success in Pancreatic Cancer Patient-Derived Xenografts: Role of Matrigel Application, Histological Subtype, and Time Management. First author DOI 10.14712/fb2025.0006↗
- Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2024.109044↗
- Prognostic Significance of Inflammation-based Scores in Pancreatic Cancer Patients Treated With Palliative Chemotherapy: A Single Institution Experience. First author DOI 10.21873/invivo.13758↗
- Introducing in vivo pancreatic cancer models for the study of new therapeutic regimens Co-author DOI 10.33699/pis.2022.101.12.584-592↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Martin Oliverius · 4 shared papers, 2022–2025 · strength 0.86
- Paper Prognostic Significance of Inflammation-based Scores in Pancreatic Cancer Patients Treated With Palliative Chemotherapy… DOI 10.21873/invivo.13758↗
- Paper Determinants of Implantation Success in Pancreatic Cancer Patient-Derived Xenografts: Role of Matrigel Application, His… DOI 10.14712/fb2025.0006↗
- Paper Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2024.109044↗
- Árpád Szabó · 3 shared papers, 2022–2025 · strength 0.55
- Paper Determinants of Implantation Success in Pancreatic Cancer Patient-Derived Xenografts: Role of Matrigel Application, His… DOI 10.14712/fb2025.0006↗
- Paper Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2024.109044↗
- Paper Introducing in vivo pancreatic cancer models for the study of new therapeutic regimens DOI 10.33699/pis.2022.101.12.584-592↗
- Pavel Souček · 3 shared papers, 2022–2025 · strength 0.55
- Paper Determinants of Implantation Success in Pancreatic Cancer Patient-Derived Xenografts: Role of Matrigel Application, His… DOI 10.14712/fb2025.0006↗
- Paper Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2024.109044↗
- Paper Introducing in vivo pancreatic cancer models for the study of new therapeutic regimens DOI 10.33699/pis.2022.101.12.584-592↗
- Renata Soumarová · 1 shared paper, 2024 · strength 0.31
- Marián Liberko · 1 shared paper, 2024 · strength 0.31
- Emin Gayibov · 1 shared paper, 2025 · strength 0.22
- R Gürlich · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.